Leap Therapeutics(LPTX) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Leap Therapeutics Reports First Quarter 2024 Financial Results Cambridge, MA – May 13, 2024 – Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the first quarter ended March 31, 2024. Leap Highlights: "We appreciate the strong support of Gilead and the new and existing institutional investors who participated in our recent $40 million financing that will enable the expansion and co ...